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Background: In Tanzania and elsewhere, medicinal plants, including Maytenus senegalensis, are still widely used in
the treatment of malaria and other ailments. The aim of the present study was to investigate the in vivo
antiplasmodial and toxic effects in mice.
Methods: Oral antiplasmodial and acute toxicity of the ethanolic root extract of M. senegalensis was evaluated in
mice. The Peters 4-day in vivo antiplasmodial effect against early rodent malaria infection in chloroquine-sensitive
Plasmodium berghei NK 65 strain in mice.
Results: The M. senegalensis extract was found non-toxic and the oral median lethal dose in mice was determined to
be greater than 1,600 mg/kg body weight. The findings revealed a significant (P = 0.001) daily increase in the level of
parasitaemia in the parasitized untreated groups and a significant (P < 0.001) dose dependent decrease in parasitaemia
in the parasitized groups treated with varying doses ranging from 25 to 100 mg/kg body weight of M. senegalensis
extract and the standard drug sulphadoxine/pyrimethamine at 25/1.25 mg/kg body weight. Overall, the dose
dependent parasitaemia suppression effects were in the order of: 25/1.25 mg/kg body weight of sulphadoxine/
pyrimethamine > 100 mg/kg > 75 mg/kg > 50 mg/kg > 25 mg/kg body weight of M. senegalensis extract.
Conclusion: The implications of these findings is that M. senegalensis ethanolic root bark extract possess potent
antiplasmodial effect and may, therefore, serve as potential sources of safe, effective and affordable anti-malarial
drugs. The displayed high in vivo antiplasmodial activity and lack of toxic effect render M. senegalensis a candidate
for the bioassay-guided isolation of compounds which could develop into new lead structures and candidates for
drug development programmes against human malaria.
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Maytenus senegalensis, which belong to the Celastraceae
family, is an abundant perennial tree that has a wider
distribution in Africa, Arabia, Afghanistan and India [1].
The decoction of the stem bark and root is used trad-
itionally in the folk medicine in Africa for the treatment
of a number of diseases and health conditions, including* Correspondence: Malebo@hotmail.com
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unless otherwise stated.malaria, fever, chest pains, rheumatism, dysmenorrhoea,
diarrhoea, dyspepsia eye infection, wounds and snake-
bites [2,3].
In Kagera region, in Tanzania, the root bark is used in
traditional medicine by traditional healers and the
community to treat malaria, fever, pain and chronic
illnesses [2,4]. The same traditional uses of M. senega-
lensis are also reported from other African countries
namely; Benin, Côte d’Ivoire, Kenya, Senegal, Sudan,
Zambia, and Zimbabwe [5-11]. Most of the population
in rural communities in Tanzania and in other African
countries relies on herbal medicines for their healthl. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Table 1 Percent Parasitaemia per dose in mg/kg body weight of mouse
Doses Percent Parasitaemia per mouse (%) Mean (%) Pvalue of Tests
vs Neg. control1 2 3 4 5
25 6.25 6.75 6.50 6.80 6.20 6.50 P < 0.001
50 3.66 3.69 3.43 3.80 3.40 3.59 P < 0.001
75 2.06 2.10 1.54 2.00 1.80 1.90 P < 0.001
100 0.90 0.96 1.16 1.08 0.90 1.10 P < 0.001
Neg. control 56.58 56.45 56.57 56.56 56.51 56.53
SP (25/1.25) 0.49 0.80 0.76 0.72 0.65 0.68
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cance of indigenous people as well as the herbal medi-
cines are generally more accessible, affordable and the
perceived efficacy and safety of the remedy [13]. Des-
pite the efforts of government of the United Republic
of Tanzania to make modern health service accessible,
available and acceptable to all, most of people in rural
areas reside distances away from the facilities and that,
the road infrastructure linking some of the communi-
ties to the health facilities are in some seasons of the
year are inaccessible, especially during rainy seasons
[14-16].
On this background coupled with other factors make it
difficult for the majority of rural dwellers to access quality
health care and unequivocally make traditional medicine
an obvious choice for them. In Kagera region in Tanzania,
dependency on traditional medicine as the first option for
rural dwellers in the treatment of malaria has been inevit-
able. Despite the popular use of M. senegalensis for mal-
aria and other ailments, few pharmacological studies have
been described in literature and there is no extensive re-
search on the toxicity of extracts of the root bark and their
pharmacological effect on malaria. Thus, the interest in
this plant was justified by its potential medicinal value
against malaria. Therefore, the aim of this study was to in-
vestigate the in vivo efficacy and safety of the root bark ex-
tract of M. senegalensis.Figure 1 Suppression of Plasmodium berghei parasitaemia exhibited b
in experimentally infected mice.Methods
Chemicals
Analar grade ethanol and dimethyl sulphoxide (DMSO)
were purchased from VWR (UK).
Plant collection and sample preparation
Root bark materials of M. senegalensis were collected by
the help of the traditional healers and community mem-
bers at Kyamlaire village in Kagera region, Tanzania. Iden-
tification of the plant species was done at the Herbarium
of the Department of Botany, University of Dar es Salaam
where a voucher specimen has been deposited (Suleman
collection No. 4998). The root bark was air dried, grinded
and phytochemical processing to get crude ethanolic ex-
tract was done. Two kilograms of air-dried and ground
root bark of M. senegalensis was soaked in 6 L ethanol for
48 hours at room temperature (about 30°C). The crude
extract was obtained by filtration, followed by evaporation
of the solvent in vacuo at 30°C so as to avoid decompos-
ition of thermally labile compounds. The afforded extract
weighing 244 g (12.2% yield) was kept at 4°C in the re-
frigerator till when needed for assay.
Animals
Swiss albino mice weighing 18–22 g and aged 6–8 weeks
raised at the Animal House of the Government Chemist La-
boratory Agency (GCLA) were used in the study. The micey different dosages of M. senegalensis in comparison to controls
Figure 2 Percent parasitaemia observed with different dosages of M. senegalensis in comparison to controls in experimentally infected mice.
Malebo et al. Malaria Journal  (2015) 14:79 Page 3 of 7were maintained on standard feed and water (ad libitum).
Approval for the study was obtained from the Ethical Com-
mittee, National Institute for Medical Research (NIMR) in
Tanzania.
Parasite
Blood-stage samples of Plasmodium berghei ANKA 65
strain were stored in liquid nitrogen in solution for cryo-
preservation of the parasite till needed for the assay.
Infection of mice
Albino mice between 6 to 8 weeks of age and weighing
between 18 to 22 grams were randomized into six
groups of five each and with the exception of the healthy
control group, all mice were inoculated intravenously in
the tail vein on day 1 with 1x107P. berghei ANKA 65
parasitized erythrocytes obtained by suitable dilution
with 0.9% NaCl of infected red blood cells from a sacri-
ficed mouse with 20% parasitaemia.
Drug administration
This was the four-day suppressive test [17,18]. The M.
senegalensis root bark ethanolic extract was dissolved in
DMSO and then diluted with distilled water to 1% DMSO
to make concentrations of 25, 50, 75 and 100 mg/kg body
weight in each 0.4 ml of the extract once a day (at 24-hour
interval) for four days post-infection (p.i.). Likewise sul-
phadoxine/pyrimethamine (SP) was dissolved in 1%
DMSO at a concentration of 25/1.25 mg/kg in 0.4 ml. TheTable 2 The calculated percentage of suppression (inhibition)
Dose in mg/kg body weight Calculation of % inhibition of parasit
25 100 - [6.5/56.53 × 100]
50 100 - [3.59/56.53 × 100]
75 100 - [1.9/56.53 × 100]
100 100 - [1.1/56.53 × 100]
Negative control 100 - [56.53/56.53 × 100]
Positive control (SP) (25/1.25 100 - [0.52/56.53 × 100]
*SP (standard drug) has no marked superiority to M. senegalensis extract at a dosefirst four groups each were treated with crude M. senega-
lensis root bark ethanolic extract once daily starting on
day 1 with 0.4 ml of each one of the test dosage through
the oral route. The fifth group was treated with standard
drug (SP) and served as the positive control. The sixth
group received the vehicle and served as untreated con-
trols. Treatments were continued for days 2, 3, and 4. The
course of infection was followed up on day 7 by a Giemsa-
stained blood smear determination of parasitaemia.
The percentage of parasitaemia for each group was
calculated using the formula:
¼ mean parasitaemia treatedð Þ  100
Mean parasitaemia control
The percent inhibition of parasitaemia for each group
was calculated using the formula
¼ 100 – mean parasitaemia treated 100ð Þ
Mean parasitaemia control
In vivo acute toxicity assessment
Crude M. senegalensis root bark ethanolic extract was
assessed for its toxicity in vivo in albino mice according to
WHO guidelines [19]. Crude M. senegalensis root bark
ethanolic extract was dissolved in DMSO and then diluted
with distilled water to 1% DMSO to make concentrations
of 200, 300, 400, 800 and 1600 mg/kg body weight. Five
groups of ten albino mice each were used during the studyof Plasmodium berghei per dose
aemia Percent inhibition P value of Pos. control vs Tests
88.50 P < 0.05
93.65 P < 0.05
96.64 P > 0.05*




Figure 3 Suppression of Plasmodium berghei parasitaemia exhibited by different dosages of M. senegalensis in comparison to controls
in experimentally infected mice.
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young adult mice were randomized and doses of M. senega-
lensis were administered by oral gavage. After drug adminis-
tration, food was withheld for 2 h. Mice were observed
individually for 4 hours after drug administration and then
at the 24 h and 48 h. All mice were observed to identify any
symptoms manifesting ill-health or behavioural changes.
Visual observation parameters included alertness, grooming,
tremors, convulsions, urination, salivation and writhing. The
median oral lethal dose calculated as the geometric mean of
doses that caused between 0 and 100% mortality (if any).
The definition of the acute toxicity used was: 0 ≤ 50 mg/kg
body weight – highly toxic; 50 ≤ 300 mg/kg body weight -
toxic; 300 ≤ 1,000 mg/kg body weight - moderately toxic;
1,000 ≤ 2,000 mg/kg body weight – mildly toxic; and
2,000 ≤ 5,000 mg/kg body weight – non-toxic.Table 4 In vivo acute toxicity of M. senegalensis ethanolStatistical analysis
Data was analysed by statistical software SPSS version 11.5
(SPSS Inc, Chicago, Illinois, USA). Numerical data pre-
sented as mean ± standard deviation, the significance of
mean difference between two independent groups was de-
termined by using Student’s t-test, and one-way analysis of
variance (ANOVA). A P value <0.05 was considered sig-
nificant. Proportional data was presented as percentages.
Significance testing of differences between proportions
was done by using Fisher’s exact test, a P value <0.05 was
considered significant.Table 3 Probit analysis of in vivo antiplasmodial activity
of M. senegalensis ethanol extract in experimental mice
Probit Antiplasmodial activity
in mg/kg BDW
Range at confidence interval
95% limits (mg/kg BDW)
ED50 3.3 1.8 to 4.9
ED75 10.2 7.2 to 13.5
ED90 28.4 21.6 to 39.3
ED99 166.5 102.4 to 349.8
Slope = 1.361 + −0.162; Natural Response. = 0.000 + −0.000; Heterogeneity = 0.04.Results
In vivo anti-plasmodial activity
The results of the in vivo antiplasmodial effect of M.
senegalensis ethanol extract showed a dose-dependent
significant decrease in malaria parasite count in mice in-
fected with P. berghei (P = 0.001). Table 1 and Figures 1
and 2 show summary of the percentage parasitaemia in
mice on day 7 post-infection (p.i.).
Based on day 7 p.i. smears, the M. senegalensis ethanol
extract dosages ranging from 25-100 mg/kg body weight,
exhibited significant suppression of parasitaemia ranging
from 88.5% to 98.1% (p = 0.001) as shown in Table 2 and
Figure 3. The highest reduction of parasitaemia was ob-
served at a dose of 100 mg/kg body weight of mice treated
with M. senegalensis ethanol extract as compared to the
negative control group. At 100 mg/kg body weight, the M.
senegalensis ethanol extract exhibited 98.1% suppression
of parasitaemia comparable to 99.1% that of SP, the posi-
tive control. The in vivo antiplasmodial activity of M. sene-
galensis was expressed by the dose inhibiting 50%, 75%,
90% and 99% of parasite growth (ED50, ED75, ED90, ED99).
The effective dose that cured 50% of test mice (ED50) was
calculated as 3.3 mg/kg body weight which indicates that
the M. senegalensis ethanol extract has high in vivo anti-
plasmodial activity in mice infected by P. berghei (Table 3).
The extract also revealed other promising effective dosesextract in experimental mice
Dose in mg/kg body weight Acute toxicity
(survival at 24 and 48 hours)
No. of mice 24 hours 48 hours
200 10 10 10
300 10 10 10
400 10 10 10
800 10 10 10
1600 10 10 10
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and 166.5 mg/kg body weight, respectively.
Acute toxicity
Results of the acute toxicity evaluation of M. senegalensis
ethanol extract are provided in Table 4. At all the tested
dosages no any mouse died at 24 and 48 hours post drug
administration. The highest tested dose was 1600 mg/kg
of body weight. The animals were not exposed to doses
higher than 1,600 mg/kg of body weight as with increas-
ing concentration, the extract precipitated and the
solution became too sticky to handle. Observations of
physical conditions, toxic symptoms showed that no any
sign of toxicity was seen in experimental mice at the
tested dosages. The therapeutic index (TI) calculated as
ratio of the LD50 and ED50 was estimated to be higher
than 113.5, indicating that M. senegalensis ethanol ex-
tract is not toxic.
Table 4 shows the toxicity manifestation parameters
observed before and after the administration of M. sene-
galensis ethanol extract. The statistical analysis of the
dosage administered to mice and the observed effects
were found significant at 5%. No any toxic effect mani-
festation was observed even at the highest dosage of
1600 mg/kg body weight of the test mouse (Table 5).
This clearly confirms that, the M. senegalensis ethanol
extract do not produce oral toxicity at the tested
dosages.
The lethal dose of M. senegalensis ethanol extract is
higher than 1,600 mg/kg body weight and hence, in a
single dose administration, the plant extract caused no
any mortality.
Discussion
The ethanolic root bark extract of M. senegalensis showed
high antiplasmodial activity against P. berghei infection in
mice as evidenced by the percentage of inhibition of para-
site development. The M. senegalensis extract exhibited
higher suppression of malaria parasites comparable to thatTable 5 Toxicity effect manifestation of M. senegalensis ethan
Response Dosage of extract administered to test mice (mg/kg
200 300 4
Before After Before After B
1. Alertness N N N N N
2. Grooming A A A A A
3. Tremors A A A A A
4. Convulsion A A A A A
5. Urination N N N N N
6. Salivation N N N N N
7. Writhing A A A A A
Key: N = normal; A = absent.of the standard antimalarial drug, SP. Maytenus senegalen-
sis extract exhibited a dose dependent activity, as the dose
increased also antiplasmodial activity increased signifi-
cantly. In addition, the observed chemosuppressive activity
suggests that the root bark extract of this plant can sup-
press parasite growth to lower levels of parasitaemia in a
long-term administration as it is practiced in traditional
medicine. However, findings showing lower antiplasmodial
effect with parasitaemia suppression of 7% and 23% of M.
senegalensis leaves and root bark, respectively, have been
reported [10]. It was furthermore revealed that, the para-
sitaemia suppression of M. senegalensis leaves and root
bark extracts were potentiated by chloroquine to 55.4%
and 56.2%, respectively [10]. High antiplasmodial effects
on parasitaemia in this study are similar to the ones re-
ported by Gessler et al. [2], whereby M. senegalensis ex-
tract at the dosage of 500 mg/kg body weight/day in four
days produced a significant reduction of parasitaemia of
90%. Previous in vitro screening revealed M. senegalensis
extract exhibits strong activity against the multi-drug re-
sistant Plasmodium falciparum strain K1 with IC50 values
of ranging from 1.0 to 3.9 μg/ml [2,20,21]. The extracts of
M. senegalensis also exhibit potent antiinflammatory, anal-
gesic and antipyretic properties in mice [22,23]. These
findings support the ethnomedical use of M. senegalensis
in the treatment of malarial and associated symptoms.
In this study, the extract of M. senegalensis did not
show any toxic effect because doses up to 1600 mg/kg
caused no any death or alter the behaviour of the tested
normal mice. It can be extrapolated that, the median le-
thal dose is thus greater than 1600 mg/kg making M.
senegalensis safety to be between slightly toxic to non-
toxic. However, Da Silva et al., in the preliminary tox-
icity study, noted signs of toxicity of M. senegalensis in
mice and rats at 1,200 mg/kg body weight [24]. How-
ever, a similar finding has not yet been found by other
researchers worked on M. senegalensis extracts. Recent
investigation in Tanzania has further revealed that, M.
senegalensis extract is practically non-toxic as it is wellol extract in experimental mice
body weight)
00 800 1600
efore After Before After Before After
N N N N N
A A A A A
A A A A A
A A A A A
N N N N N
N N N N N
A A A A A
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tal mice. In the acute toxicity study, it was indicated
that, the extract at a dose of 5,000 mg/kg body weight
caused neither visible signs of toxicity nor mortality in
mice, suggesting its safety [25]. In the classification of
toxicity, the extract with an LD50 > 5,000 mg/kg body
weight per os (p.o.) is considered to be non-toxic. Inves-
tigation in Mali revealed that, the aqueous extract of M.
senegalensis administrated orally in mice caused no any
toxicity to mice [22]. Previous findings also suggest that
M. senegalensis is practically non-cytotoxic as it exhib-
ited IC50 values of 87.82 ± 3.02 and >90.00 against mam-
malian cell lines viz; Vero cell lines and Rat skeletal
myoblast (L-6) cells, respectively [20,21]. The oral non-
toxic nature of M. senegalensis and the use of this plant
against malaria and other ailments go hand in hand with
scientific evidence provided by this study.Conclusion
The oral administration of graded M. senegalensis etha-
nol extract doses (25–100 mg/ kg body weight) to mice
for 4 days significantly suppressed malaria parasites de-
velopment in vivo against Plasmodium berghei NK 65
strain in experimental mice. Higher doses of M. senega-
lensis ethanol extract (200–1600 mg/ kg body weight)
could not result in death and was not associated with
adverse effects. According to these results, the M. sene-
galensis ethanol extract could be categorized as a non-
toxic crude drug that acts harmlessly under the normal
traditional usage. The observed large safety window of
M. senegalensis extract is responsible for its widespread
use in Tanzania and other countries without acute toxic
symptoms and complications. Hence, M. senegalensis may
be exploited as herbal pharmaceuticals for malaria, fever
and pains. The implications of these findings is that M.
senegalensis ethanolic root bark extract possess potent
antiplasmodial effect and may therefore serve as potential
sources of safe, effective and affordable antimalarial drugs.
The displayed high in vivo antiplasmodial activity and lack
of toxic effect render M. senegalensis a candidate for the
bioassay-guided isolation of compounds which could de-
velop into new lead structures and candidates for drug de-
velopment programmes against human malaria.Competing interests
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